2012
DOI: 10.1016/j.sleep.2012.04.016
|View full text |Cite
|
Sign up to set email alerts
|

Respiratory response to proton pump inhibitor treatment in children with obstructive sleep apnea syndrome and gastroesophageal reflux disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
19
0
1

Year Published

2013
2013
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(22 citation statements)
references
References 32 publications
2
19
0
1
Order By: Relevance
“…One study identified GER as a risk factor for adenoid regrowth and revision adenoidectomy [20]. It has also been proposed that children with OSA be screened for GER after proton-pump inhibitor therapy was demonstrated to improve AHI scores in children with both OSA and GER [22]. It should be noted that the greatest benefit in this study was seen in school-age children with mild OSA.…”
Section: Discussionmentioning
confidence: 60%
See 1 more Smart Citation
“…One study identified GER as a risk factor for adenoid regrowth and revision adenoidectomy [20]. It has also been proposed that children with OSA be screened for GER after proton-pump inhibitor therapy was demonstrated to improve AHI scores in children with both OSA and GER [22]. It should be noted that the greatest benefit in this study was seen in school-age children with mild OSA.…”
Section: Discussionmentioning
confidence: 60%
“…Several studies have also characterized the impact of reflux on obstructive sleep apnea [20][21][22]. One study identified GER as a risk factor for adenoid regrowth and revision adenoidectomy [20].…”
Section: Discussionmentioning
confidence: 99%
“…24,25 Proton pump inhibitor treatment reduces the obstructive events and improves the apnea hypopnea index in OSA patients. 26,27 In patients with OSA, intrathoracic pressure is increased negatively during an apnea. In addition, hyperventilation after sleep apnea is related to the mechanism of GERD.…”
Section: Discussionmentioning
confidence: 99%
“…An enzymelinked immunosorbent assay (ELISA) was used to test for anti-HP IgG in sera from patients of both SDB and reference groups. Inclusion criteria for the SDB group were: patients with SDB diagnosed according to previously described criteria [30]; a negative history of HP eradication therapy. Exclusion criteria for the SDB group included: craniofacial anomalies, genetic syndromes, patients taking any medications, and patients with acute infectious symptoms.…”
Section: Study Participantsmentioning
confidence: 99%
“…Pediatric causes of OSAS include most notably adenotonsillar hypertrophy. Other local and general conditions such as genetic factors, craniofacial malformations, neuromuscular diseases, obesity, or gastroesophageal reflux disease have also been implicated as risk factors [3,5,9,14,27,30,31].…”
Section: Introductionmentioning
confidence: 99%